Cargando…

Randomized Placebo Control Study of Metformin in Psoriasis Patients with Metabolic Syndrome (Systemic Treatment Cohort)

BACKGROUND: Psoriasis has been found to be associated with obesity, metabolic syndrome (MS), diabetes, and cardiovascular risk factors. Metformin treatment showed improvement in cardiovascular risk factors and hyperinsulinemia. OBJECTIVE: To evaluate the efficacy and safety of metformin in psoriasis...

Descripción completa

Detalles Bibliográficos
Autores principales:	Singh, Surjit, Bhansali, Anil
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2017
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5477448/ https://www.ncbi.nlm.nih.gov/pubmed/28670544 http://dx.doi.org/10.4103/ijem.IJEM_46_17

Ejemplares similares

Randomized placebo control study of insulin sensitizers (Metformin and Pioglitazone) in psoriasis patients with metabolic syndrome (Topical Treatment Cohort)
por: Singh, Surjit, et al.
Publicado: (2016)

Prevalence of Metabolic Syndrome in Psoriasis and Levels of Interleukin-6 and Tumor Necrosis Factor-α in Psoriasis Patients with Metabolic Syndrome: Indian Tertiary Care Hospital Study
por: Singh, Surjit, et al.
Publicado: (2017)

Metformin upregulates mitophagy in patients with T2DM: A randomized placebo‐controlled study
por: Bhansali, Shipra, et al.
Publicado: (2020)

Effect of Linagliptin and Voglibose on metabolic profile in patients with Type 2 Diabetes: a randomized, double-blind, placebo-controlled trial
por: Parthan, Girish, et al.
Publicado: (2018)

The Combined Use of Metformin and Methotrexate in Psoriasis Patients with Metabolic Syndrome
por: Tam, Huynh Thi Xuan, et al.
Publicado: (2022)

Metformin treatment of antipsychotic-induced dyslipidemia: an analysis of two randomized, placebo-controlled trials
por: Wu, R-R, et al.
Publicado: (2016)

Psoriasis and metabolic syndrome: implications for the management and treatment of psoriasis
por: Wu, J.J., et al.
Publicado: (2022)

Systemic Role for Vitamin D in the Treatment of Psoriasis and Metabolic Syndrome
por: Fu, Lisa Wenyang, et al.
Publicado: (2011)

Effect of a Dual PPAR α/γ agonist on Insulin Sensitivity in Patients of Type 2 Diabetes with Hypertriglyceridemia- Randomized double-blind placebo-controlled trial
por: Jain, Nimisha, et al.
Publicado: (2019)

A Randomized Placebo-Controlled Trial of Metformin for Frailty Prevention in Older Adults
por: Tavabi, Amir, et al.
Publicado: (2021)

Probiotic vs. placebo and metformin: probiotic dietary intervention in polycystic ovary syndrome – A randomized controlled trial
por: Borzan, Valentin, et al.
Publicado: (2023)

Effect of metformin versus placebo on metabolic factors in the MA.32 randomized breast cancer trial
por: Goodwin, Pamela J., et al.
Publicado: (2021)

Metformin in the management of fibrocystic breast disease: a placebo-controlled randomized clinical trial
por: Alipour, Sadaf, et al.
Publicado: (2021)

The efficacy of metformin for the treatment of psoriasis: a meta-analysis study
por: Huang, Zhuo, et al.
Publicado: (2023)

Favourable metabolic profile sustains mitophagy and prevents metabolic abnormalities in metabolically healthy obese individuals
por: Bhansali, Shipra, et al.
Publicado: (2017)

Psoriasis and Metabolic Syndrome
por: Malkic Salihbegovic, Eldina, et al.
Publicado: (2015)

Dapagliflozin add-on to metformin in type 2 diabetes inadequately controlled with metformin: a randomized, double-blind, placebo-controlled 102-week trial
por: Bailey, Clifford J, et al.
Publicado: (2013)

Incidence and predictors of metabolic syndrome in Asian-Indians: a 10-year population-based prospective cohort study
por: Jayant, Satyam Singh, et al.
Publicado: (2023)

Correction: Dapagliflozin add-on to metformin in type 2 diabetes inadequately controlled with metformin: a randomized, double-blind, placebo-controlled 102-week trial
por: Bailey, Clifford J, et al.
Publicado: (2013)

Is Metformin a Possible Beneficial Treatment for Psoriasis? A Scoping Review
por: Stanescu, Ana Maria Alexandra, et al.
Publicado: (2021)

A Randomized, Double-blind, Placebo-controlled Clinical Study to Investigate the Efficacy of Herring Roe Oil for Treatment of Psoriasis
por: TVEIT, Kåre Steinar, et al.
Publicado: (2020)

Metabolic bone disease: Newer perspectives
por: Bhansali, Anil
Publicado: (2012)

Long-term treatment with metformin in obese, insulin-resistant adolescents: results of a randomized double-blinded placebo-controlled trial
por: van der Aa, M P, et al.
Publicado: (2016)

Ipragliflozin in combination with metformin for the treatment of Japanese patients with type 2 diabetes: ILLUMINATE, a randomized, double-blind, placebo-controlled study
por: Kashiwagi, A, et al.
Publicado: (2015)

Effects of Low Dose Metformin on Metabolic Traits in Clozapine-Treated Schizophrenia Patients: An Exploratory Twelve-Week Randomized, Double-Blind, Placebo-Controlled Study
por: Chiu, Chih-Chiang, et al.
Publicado: (2016)

Adjunctive metformin for antipsychotic-induced dyslipidemia: a meta-analysis of randomized, double-blind, placebo-controlled trials
por: Jiang, Wen-Long, et al.
Publicado: (2020)

Metformin exposure, maternal PCOS status and fetal venous liver circulation: A randomized, placebo-controlled study
por: Grindheim, Sindre, et al.
Publicado: (2022)

Metformin reduces SARS-CoV-2 in a Phase 3 Randomized Placebo Controlled Clinical Trial
por: Bramante, Carolyn T, et al.
Publicado: (2023)

Prevalence of Metabolic Syndrome in Patients with Psoriasis
por: Zindancı, Ilkin, et al.
Publicado: (2012)

Metabolic Syndrome and Skin: Psoriasis and Beyond
por: Padhi, Tanmay, et al.
Publicado: (2013)

Psoriasis and its Association with Metabolic Syndrome
por: Agarwal, Komal, et al.
Publicado: (2023)

Correction: Effects of Low Dose Metformin on Metabolic Traits in Clozapine-Treated Schizophrenia Patients: An Exploratory Twelve-Week Randomized, Double-Blind, Placebo-Controlled Study
por: Chiu, Chih-Chiang, et al.
Publicado: (2018)

Metabolic Syndrome and Psoriasis: A Case–Control Study in Kabul, Afghanistan
por: Aalemi, Ahmad Khalid, et al.
Publicado: (2021)

Efficacy and safety of teneligliptin added to metformin in Chinese patients with type 2 diabetes mellitus inadequately controlled with metformin: A phase 3, randomized, double‐blind, placebo‐controlled study
por: Ji, Linong, et al.
Publicado: (2021)

Association between metabolic syndrome and psoriasis: a meta-analysis of observational studies with non-psoriasis control groups
por: Qiao, Ju, et al.
Publicado: (2020)

Practical recommendations for systemic treatment in psoriasis according to age, pregnancy, metabolic syndrome, mental health, psoriasis subtype and treatment history (BETA‐PSO: Belgian Evidence‐based Treatment Advice in Psoriasis; part 1)
por: Lambert, J.L.W., et al.
Publicado: (2020)

Chinese herbal Pulian ointment in treating psoriasis vulgaris of blood-heat syndrome: a multi-center, double-blind, randomized, placebo-controlled trial
por: Li, Nuo, et al.
Publicado: (2017)

Apremilast Long-Term Safety Up to 5 Years from 15 Pooled Randomized, Placebo-Controlled Studies of Psoriasis, Psoriatic Arthritis, and Behçet’s Syndrome
por: Mease, Philip J., et al.
Publicado: (2023)

Effect of metformin on thyroid stimulating hormone and thyroid volume in patients with prediabetes: A randomized placebo-controlled clinical trial
por: Karimifar, Mozhgan, et al.
Publicado: (2014)

Effect of Metformin For Decreasing Proliferative Marker in Women with Endometrial Cancer: A Randomized Double-Blind Placebo-Controlled Trial
por: Petchsila, Kittisak, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_cqp6le7c82mg4jebjb8nbitjaj